Converting Patients with Type 2 Diabetes to Insulin

Walling, Anne D.
February 2004
American Family Physician;2/15/2004, Vol. 69 Issue 4, p952
Academic Journal
Discusses research being done on the importance of addressing patients' concerns and medical issues involved in initiating insulin therapy. Reference to a study by M. McIntyre et al published in the July 2003 issue of the journal "Practitioner"; Hyperglycemic symptoms in type-2 diabetic patients; Considerations on optimizing oral medications; Benefits from continuing metformin therapy.


Related Articles

  • British Medical Journal: Patients with Type 2 diabetes may not benefit from oral medication as well as insulin.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article focuses on a study according to which treatment of patients suffering from type II diabetes, with oral glucose lowering drug and insulin could not benefit them.

  • Clinical Potential of Insulin Therapy in Critically Ill Patients. Mesotten, Dieter; Berghe, Greet Van den // Drugs;2003, Vol. 63 Issue 7, p625 

    Stress of critical illness is often accompanied by hyperglycaemia, whether or not the patient has a history of diabetes mellitus. This has been considered to be part of the adaptive metabolic response to stress. The level of hyperglycaemia in patients with acute myocardial infarction (MI) or...

  • Sliding scale insulin. Lorber, Daniel L.; Lorber, D L // Diabetes Care;Nov2001, Vol. 24 Issue 11, p2011 

    Comments on an article which proposed the use of sliding scale insulin in the management of hyperglycemic crises in diabetics. Information on sliding scale insulin; Limitations.

  • Can Newer Therapies Delay the Progression of Type 2 Diabetes Mellitus? Edward Horton // Endocrine Practice;Jul2008, Vol. 14 Issue 5, p625 

    Objective: To review the multifactorial and progressive nature of type 2 diabetes mellitus (T2DM), the consequences of its progression, and the potential of traditional and newer therapies to delay the progression of this disease.Methods: The relevant literature is reviewed, and the mechanisms...

  • Oral antihyperglycemic therapy for type 2 diabetes mellitus. Cheng, Alice Y. Y.; Fantus, I. George // CMAJ: Canadian Medical Association Journal;1/18/2005, Vol. 172 Issue 2, p213 

    DIABETES MELLITUS IS A CHRONIC DISEASE that is growing in prevalence worldwide. Pharmacologic therapy is often necessary to achieve optimal glycemic control in the management of diabetes. Orally administered antihyperglycemic agents (OHAs) can be used either alone or in combination with other...

  • Sliding-Scale Insulin. Kitabchi, Abbas E.; Nyenwe, Ebenezer // Diabetes Care;Sep2007, Vol. 30 Issue 9, p2409 

    The article focuses on the use of sliding-scale regular insulin (SSI) in the management of patients with diabetes. It mentions a study in which two groups of similar insulin-naive patients admitted to general medical wards were compared regarding efficacy of basal-bolus insulin versus SSI. It...

  • Insulintherapie bei Diabetes mellitus. Lechleitner, Monika; Roden, Michael; Weitgasser, Raimund; Ludvik, Bernhard; Fasching, Peter; Hoppichler, Friedrich; Kautzky-Willer, Alexandra; Schernthaner, Guntram; Prager, Rudolf; Wascher, T. C. // Wiener Klinische Wochenschrift;Dec2012 Supplement, Vol. 124, p17 

    Hyperglycemia contributes to morbidity and mortality in patients with diabetes. Thus, reaching treatment targets with regard to control of glycemia is a central goal in the therapy of diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for...

  • Diabetes Mellitus Update. Seelandt, Katherine K. // Journal of Continuing Education in Nursing;Mar/Apr2007, Vol. 38 Issue 2, p54 

    The article presents information on a research on diabetes mellitus. The disease is spreading rapidly with the increasing number of patients suffering from it. The use of insulin is also increasing with the increasing number of patients. Oral antihyperglycemic agents are used for the patients...

  • Refining Treatment of Type 2 Diabetes. Padilla, Alfred J. // Cortlandt Forum;09/25/99, Vol. 12 Issue 9, p168 

    Presents an overview of treatments of type 2 diabetes. Three factors that contribute to the hyperglycemia of type 2 diabetes; Disruption of insulin secretion in type 2 diabetes; Five classes of oral agents available for the treatment of patients. INSETS: Case 1: A Reversible Diabetogenic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics